Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 105592
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105592
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105592
Figure 5 Decision curve analysis.
A and B: Decision curve analysis (DCA) for diabetic peripheral neuropathy prediction in the training cohort (A) and validation cohort (B); C and D: DCA for type 2 diabetes mellitus prediction in the training cohort (C) and validation cohort (D). T2DM: Type 2 diabetes mellitus; DPN: Diabetic peripheral neuropathy; TC: Training cohort; VC: Validation cohort.
- Citation: Xu WS, Xing H, Wang QQ, Qi H, He JT, Jin T, Kan YP, Sun SY, Wang JY, Lin FQ. Identification and validation of serum amino acids as diagnostic biomarkers for diabetic peripheral neuropathy. World J Diabetes 2025; 16(6): 105592
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/105592.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.105592